Search Results
Oct 27, 2025, 06:00 ET Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Deep Track Capital, HealthCap, Invus, Avoro Ventures, Maj Invest Equity, and Rock Springs Capital. In connection with this financing, Joe Anderson, PhD, Partner at Sofinnova Partners, will join the Hemab Board.
More news about: Hemab Therapeutics
Oct 26, 2025, 13:00 ET Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
Radiation Shielding System with Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha
More news about: Egg Medical
Oct 26, 2025, 13:00 ET Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
Radiation Shielding System with Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha
More news about: Egg Medical
Oct 24, 2025, 14:39 ET Laplace Interventional completes Trans-Jugular US Early Feasibility Study and adds Trans-Femoral approach
patients, according to the physician's preference for access," said Dr. Goel. Laplace Interventional Founder and CEO, Ramji Iyer, PhD said, "The completion of US EFS using the TJ approach as well as successful completion of 2 first-in-human (FIH) TF cases are both significant achievements
More news about: Laplace Interventional, Inc.
Oct 24, 2025, 13:02 ET Sampled and AutoGen Announce Partnership for Specialized Nucleic Acid Extraction and Multiomic Workflows
high-quality results across a wide range of applications. Media ContactsCaroline Mitchell, PhDDirector, Content & Creative Strategy, [email protected]
More news about: Sampled
Oct 24, 2025, 12:30 ET Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
"These findings reinforce PTK7's promise as one of the most compelling and underexplored ADC targets in oncology," said Dave Lennon, PhD, President and Chief Executive Officer, Whitehawk Therapeutics. "As the third most abundant tumor marker across all cancer patients – present in approximately
More news about: Whitehawk Therapeutics, Inc.
Oct 24, 2025, 11:46 ET Interactive Natural Hazard Risk Dashboard for Mortgages Now Live via UMD Smith
the University of Maryland, College Park, the Smith School offers undergraduate, full-time and flex MBA, executive MBA, online MBA, business master's, PhD and executive education programs, as well as outreach services to the corporate community. The school offers its degree, custom and certification programs
More news about: University of Maryland's Robert H. Smith School of Business
Oct 24, 2025, 09:54 ET SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting
MD, MS, FAES, The Ohio State University Wexner Medical Center, Columbus, Ohio Raman Sankar, MD, PhD, FAAN, FAES, David Geffen School of Medicine at UCLA, Los Angeles, California John M. Stern, MA,
More news about: SK Life Science, Inc.
Oct 24, 2025, 09:00 ET RO COLLABORATES WITH LEADING OBESITY RESEARCHERS TO DEBUT NEW, VALIDATED SCALE TO MEASURE 'FOOD NOISE'
advancements in the scientific understanding of food noise and, hopefully, accelerate the discovery of effective interventions," said David B. Allison, PhD, Professor of Pediatrics and Endowed Chair and Director of USDA-ARS Children's Nutrition Research Center at Baylor College of Medicine. Dr. Allison helped
More news about: Ro
Oct 24, 2025, 08:30 ET Lilly to Acquire Adverum Biotechnologies
Jason Awe, PhD; [email protected] (Adverum)
More news about: Eli Lilly and Company
Oct 24, 2025, 07:29 ET Sobi showcases new data across rare inflammatory conditions at ACR 2025
Presenting Author: Dr. David B. Beck, MD, PhD, Division of Rheumatology, NYU Langone
More news about: Swedish Orphan Biovitrum AB
Oct 24, 2025, 04:00 ET Renalys Pharma to be Acquired by Chugai Pharmaceutical
company recognized for its rare-disease and nephrology expertise, will accelerate access for patients across Asia. BT Slingsby, MD, PhD, MPH, Representative Director, Chairman & CEO, and Co-Founder of Renalys, stated: "Renalys was built to close Asia's drug lag with a simple promise:
More news about: Renalys Pharma, Inc.
Oct 24, 2025, 00:30 ET IndiaWorks Energy: Powering Germany's Green Transition with India's Skilled Workforce
IndiaWorks GmbH and IndiaWorks Energy GmbH, previously served on the Executive Board of the Chamber of Crafts Freiburg. With a PhD in Economics, he connects business, policy, and trade associations to build sustainable, future-ready skilled-labor ecosystems. "We
More news about: IndiaWorks Energy
Oct 24, 2025, 00:00 ET New release 'When Enough Is Never Enough' shows how to cultivate true contentment from within
When Enough Is Never Enough" (published by Balboa Press), Oliver Ross, JD, PhD, addresses this question with clarity, compassion, and hard-won insight.
More news about: Balboa Press
Oct 23, 2025, 18:15 ET London Blockchain Conference 2025 Concludes with Key Insights on Digital Trust, Decentralised Innovation and Smart Governance
Blockchain: Connecting Global Impact with Local Action for a Sustainable Future: Louisa Richmond-Coggan, PhD, Founder & Principal Consultant, LRC Wildlife Conservation Consuting, Genevieve Leveille, CEO nd Principal Founder, AgriLedger, James McBreen, Senior
More news about: London Blockchain Conference
Oct 23, 2025, 11:10 ET During National Breast Cancer Awareness Month, Alcohol Justice Calls for Recognition of the Breast Cancer-Alcohol Link
day "There is no such thing as a safe level of drinking," said Robert Lipton, PhD, Scientific Director of Alcohol Justice. "That's crystal clear when you look at breast cancer." Despite the Surgeon General's
More news about: Alcohol Justice
Oct 23, 2025, 10:30 ET Gentuity Announces Activities and Presence to Showcase Advanced Intravascular Imaging Solutions at TCT 2025
Practice" presented by Andreas Kalogeropoulos, MD, PhD "Small Vessel Imaging for DCB Planning" presented by Evan Shlofmitz, DO "Integration of Emerging PCI Planning Tools" presented by Hiram Bezerra, MD, PhD To
More news about: Gentuity, LLC
Oct 23, 2025, 10:00 ET Pillar Biosciences to Showcase NGS Research Insights at 2025 AMP Meeting
Biomarkers in Liquid Biopsy from Non-Small Cell Lung Cancer and Breast Cancer Using Targeted NGS-Based Assays," presented by Dr. Beatriz Bellosillo, PhD, Hospital del Mar and Ryan Demers, MSc, AstraZeneca (9:00-9:50 AM, Room 159, Level 1)
More news about: Pillar Biosciences, Inc.
Oct 23, 2025, 09:00 ET New York Regional Diabetes Research Center Receives $10M Award from NIH
York City's large and diverse patient population. The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master's degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country,
More news about: Albert Einstein College of Medicine
Oct 23, 2025, 08:30 ET Global Action to End Smoking Completes Agricultural Transformation Centre in Malawi
In addition to the creation of the physical Centre, Global Action's grantmaking activities in Malawi have provided scholarships for master's and PhD students to learn innovative agricultural practices, which has led several to become successful entrepreneurs. Grantees have also supported the Malawi
More news about: Global Action to End Smoking
Oct 23, 2025, 08:15 ET Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
approach in Myelodysplastic Syndromes and supports our commitment to developing new treatment options for patients living with MDS," said David Bearss, PhD, Chief Executive Officer of Halia Therapeutics. "Ofirnoflast represents a first-in-class approach to modulating inflammasome biology, an upstream driver
More news about: Halia Therapeutics
Oct 23, 2025, 08:15 ET Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
approach in Myelodysplastic Syndromes and supports our commitment to developing new treatment options for patients living with MDS," said David Bearss, PhD, Chief Executive Officer of Halia Therapeutics. "Ofirnoflast represents a first-in-class approach to modulating inflammasome biology, an upstream driver
More news about: Halia Therapeutics
Oct 23, 2025, 08:00 ET 2 New Published Studies Highlight SeptiCyte RAPID's Strong Performance and Clinical Utility in Post Cardiac Surgery Patients
post cardiovascular surgical patients and in a group of patients developing occlusive mesenteric ischemia with secondary sepsis" stated Roy Davis, MD, PhD, MHA, Chief Medical Officer of Immunexpress. "We also see a continued pattern of SeptiCyte RAPID outperforming some traditional biomarkers used for discriminating
More news about: Immunexpress, Inc.
Oct 23, 2025, 07:00 ET HanchorBio's Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology
Oncology affirms the scientific rigor and innovation behind HCB101 and emphasizes its differentiated preclinical foundation," said Scott Liu, PhD, Chairman, CEO, and Founder of HanchorBio. "Importantly, these insights are being directly translated into clinical studies: combined with standard-of-care,
More news about: HanchorBio Inc.
Oct 22, 2025, 20:00 ET 希爾思寵物營養宣布 2025 年希爾思全球研討會的主題為「Strong Science, Long Lives」，以推進高齡寵物的專業照護
Natasha Olby （ Vet MB 、 PhD 、 MRCVS 、 DACVIM （腦神經科）），現任北卡羅來納州立大學獸醫神經學與腦神經外科教授。她將探討高齡犬隻的活動度喪失問題。
More news about: Hill's Pet Nutrition